Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
| ▸ | VHL | P40337 | 1/20 | 0.33 |
| ▸ | ELOC | Q15369 | 1/20 | 0.33 |
| ▸ | ELOB | Q15370 | 1/20 | 0.33 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.33 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5376086 | 0.91 | TSHR (0.43) | TSHRPRSS1PRSS2PRSS3VHL | |
| SCHEMBL1792657 | 0.83 | CA2 (0.45) | TSHRCA12CA1CA2CA4 | |
| SCHEMBL6870559 | 0.82 | ALDH1A1 (0.38) | TSHR | |
| SCHEMBL5370217 | 0.81 | — | — | |
| SCHEMBL5380526 | 0.81 | — | — | |
| SCHEMBL23356017 | 0.78 | LOXL2 (0.44) | CA12CA1CA2CA4CA6 | |
| SCHEMBL5369605 | 0.78 | CA1 (0.33) | CA1CA2 | |
| SCHEMBL29169705 | 0.78 | TSHR (0.37) | TSHRPRSS1PRSS2PRSS3VHL | |
| SCHEMBL2232785 | 0.77 | — | — | |
| Ammonia Solution, Strong SCHEMBL27826486 | 0.77 | CYP2A6 (0.39) | TSHRCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279828-A1 | ELECTROGRAFTED FILMS FOR DNA SYNTHESIS | Nanjing GenScript Biotech Co., Ltd. (CN) | 2024-08-22 | — | — | US | claimed |
| EP-4347110-A1 | ELECTROGRAFTED FILMS FOR DNA SYNTHESIS | Genscript USA Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| CN-117480008-A | Electro-grafted membranes for DNA synthesis | 金斯瑞美国有限公司 | 2024-01-30 | — | — | CN | claimed |
| WO-2022256303-A1 | ELECTROGRAFTED FILMS FOR DNA SYNTHESIS | GENSCRIPT USA INC. (US) | 2022-12-08 | — | — | WO | claimed |
| US-20240279828-A1 | ELECTROGRAFTED FILMS FOR DNA SYNTHESIS | Nanjing GenScript Biotech Co., Ltd. (CN) | 2024-08-22 | — | — | US | disclosed |
| EP-4347110-A1 | ELECTROGRAFTED FILMS FOR DNA SYNTHESIS | Genscript USA Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| CN-117480008-A | Electro-grafted membranes for DNA synthesis | 金斯瑞美国有限公司 | 2024-01-30 | — | — | CN | disclosed |
| WO-2022256303-A1 | ELECTROGRAFTED FILMS FOR DNA SYNTHESIS | GENSCRIPT USA INC. (US) | 2022-12-08 | — | — | WO | disclosed |
| EP-1276726-A2 | SUBSTITUTED PHENYL FARNESYLTRANSFERASE INHIBITORS | Abbott Laboratories (US) | 2003-01-22 | — | — | EP | disclosed |
| US-20020019527-A1 | Substituted phenyl farnesyltransferase inhibitors | ABBOTT LABORATORIES | 2002-02-14 | — | — | US | disclosed |
| WO-2001081316-A2 | SUBSTITUTED PHENYL FARNESYLTRANSFERASE INHIBITORS | ABBOTT LABORATORIES (US) | 2001-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240279828-A1 | ELECTROGRAFTED FILMS FOR DNA SYNTHESIS | DNMT3A, DNMT1, DNMT3B | TSHR 2333/4885PRSS1 2891/4885PRSS2 2886/4885 |
| US-20020019527-A1 | Substituted phenyl farnesyltransferase inhibitors | FNTA, FNTB, SLC10A1 | TSHR 3465/4885PRSS1 261/4885PRSS2 687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.